← SynDRA
PFI 3
SynDRA canonical compound SYN1706214 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PBRM1 | SMARCA4 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BET bromodomain inhibitor
- SMARCA4 INHIBITOR
- PBRM1 INHIBITOR
Cross-references
Synonyms
- PFI-3
- IN2080
- Pfi-3
- CHEBI:149519
- compound 16 [PMID: 27115555]
- PF-6687252
- compound 16 (PMID: 27115555)
- RefChem:172298
- PFI3
- MFCD28100807
- PF-06687252
- GTPL7915
- orb1300329
- PFI-3?
- SCHEMBL19730380
- SCHEMBL29373926
- EX-A520
- GLXC-04442
- BDBM50158688
- NSC783642
- s7315
- AKOS024458481
- CCG-267721
- CS-3455
- NSC-783642
- PFI-3, >=98% (HPLC)
- NCGC00371001-09
- AC-35944
- BP-25372
- BS-15703
- DA-56766
- HY-12409
- T6939
- F811913
Look up PFI 3 in the interactive SynDRA portal →